EC

Global Monoclonal Antibodies Market 2023 to 2033: Players Include Merck & Co, Abbott Laboratories, Biogen and AstraZeneca - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023
Health, Biotechnology, Royal commission, Mab, Knowledge, Degenerative disease, Conditional sentence, Neurodegeneration, Growth, Region, Therapy, Patient, European Commission, Workforce, Research, Cancer, NSA product types, Atlas, Bristol Myers Squibb, Incidence, USD, Mesothelioma, EC, Fine chemical, Vaccine, Pharmaceutical industry, Ipilimumab

The "Monoclonal Antibodies Market by Source Type, Production Type, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Monoclonal Antibodies Market by Source Type, Production Type, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
  • The monoclonal antibodies market size is estimated to be USD 189,432 million in 2022 and is expected to witness a CAGR of 11.42% during the forecast period 2023-2033.
  • Strategic initiatives performed by top companies for the development of mAb products is expected to drive the market.
  • For instance, Atlas Antibodies AB and T-Cure Bioscience, Inc. collaborated together to produce and supply CT83 mAbs in October 2021.

Global Baby Feeding Bottles Market Report 2022: A $2.94 Billion Market in 2020 - Forecasts to 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Consumer, Baby, Maternity, Online, Drink, BPA, Royal commission, Child, National Health Policy, Internet, FDA, Knowledge, Food and Drug Administration, Nestlé, Health, Columbidae, Supermarket, Policy, Growth, Food, European Commission, Urbanization, Workforce, Sale, Parent, Stainless steel, Hygiene, Investment, Infant, EC, Milk, Online shopping, Bottled water, Retail, Agriculture, Toy

The "Global Baby Feeding Bottles Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Baby Feeding Bottles Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The booming global e-commerce industry is also a major factor that is driving the market growth of baby feeding bottles globally.
  • Moreover, many baby feeding bottle manufacturers have opened their own online selling platforms in order to expand their customer base, thereby bolstering the overall market growth of baby feeding bottles.
  • The market for baby feeding bottles made from new materials such as silicone and stainless steel is also gaining momentum, thus positively impacting the global baby feeding bottle market.

Global IoT WAN Markets, 2022-2027: Cellular and Non-Cellular Technologies and Solutions - 5G IoT will Drive the Majority of New Implementations with Communication Service Provider Network Expansion - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Internet, 5G, Mobile, Wireless, Technology, Telecommunications, Ecosystem, News, Temperature, Wide area network, Pressure, IOT, Internet of things, Environment, Sound, Motion, WAN, LPWAN, Light, EC, M2M, Mobile phone, Video game console

The report assesses developments in the IoT WAN ecosystem, analyzes use cases, and provides a view into the future of IoT WAN communications.

Key Points: 
  • The report assesses developments in the IoT WAN ecosystem, analyzes use cases, and provides a view into the future of IoT WAN communications.
  • The report includes detailed forecasts for cellular and non-cellular IoT WANs 2022 to 2027.
    Who are the cellular and non-cellular solution providers for IoT WAN?
  • Who are the key players within the wireless IoT WAN ecosystem and why?
  • Why Low-Power Wide Area Network (LPWAN) is considered the key technology for wireless IoT WAN?

Dalata Hotel Group PLC: Total Voting Rights

Retrieved on: 
Thursday, February 2, 2023
Dalata Hotel Group, EC, Security (finance), Medical device

In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Dalata Hotel Group plc announces that:

Key Points: 
  • In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Dalata Hotel Group plc announces that:
    As of 1 February 2023, Dalata Hotel Group plc’s share capital consists of 222,871,722 Ordinary Shares of nominal value €0.01 each.
  • Dalata Hotel Group plc does not hold any Ordinary Shares in treasury.
  • Therefore, the total number of voting rights in Dalata Hotel Group plc is 222,871,722.
  • The above figure may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Dalata Hotel Group plc under the Transparency (Directive 2004/109/EC) Regulations 2007.

CoinShares Digital Securities Limited: Choice of home Member State & competent authority

Retrieved on: 
Thursday, February 2, 2023
Council, Transparency, AMF, European Parliament, Directive, Digital, Transparency Directive, European, EC, Medical device

In accordance with article 222-1 of the General Regulation of the Autorité des Marchés Financiers (AMF), CoinShares Digital Securities Limited specifies that its home Member State, according to the Directive 2004/109/EC of the European Parliament and of the Council of December 15th, 2004 (the Transparency Directive) modified, is France and as a consequence, the competent authority for the control of the compliance with its obligations regarding regulated information is the Autorité des Marchés Financiers.

Key Points: 
  • In accordance with article 222-1 of the General Regulation of the Autorité des Marchés Financiers (AMF), CoinShares Digital Securities Limited specifies that its home Member State, according to the Directive 2004/109/EC of the European Parliament and of the Council of December 15th, 2004 (the Transparency Directive) modified, is France and as a consequence, the competent authority for the control of the compliance with its obligations regarding regulated information is the Autorité des Marchés Financiers.

Cairn Homes Plc: Total Voting Rights

Retrieved on: 
Thursday, February 2, 2023
Greater Dublin Area, Euronext, Treasury, Cairn, EC, Central bank, Security (finance)

Dublin/London, 1 February 2023: In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, (as amended) Cairn Homes plc (the “Company”) (Euronext Dublin/LSE: CRN) confirms that the total number of Ordinary Shares of €0.001 each in issue as at the date of this notice, was 685,777,452.

Key Points: 
  • Dublin/London, 1 February 2023: In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, (as amended) Cairn Homes plc (the “Company”) (Euronext Dublin/LSE: CRN) confirms that the total number of Ordinary Shares of €0.001 each in issue as at the date of this notice, was 685,777,452.
  • Each Ordinary Share carries one vote, therefore the total number of voting rights is 685,777,452.
  • Cairn Homes plc (“Cairn”) is the leading Irish homebuilder committed to building high-quality, competitively-priced, sustainable new homes in great locations.
  • A new Cairn home is thoughtfully designed and built to last with a focus on creating shared spaces and environments where communities prosper.

Spinal Muscular Atrophy Treatment Market Worth $18.0 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Wednesday, January 11, 2023
Clinical trial, Ageing, SMA, Gene therapy, EC, UNC Medical Center, Food, Therapy, Research, Spinal muscular atrophy, Genentech, Royal commission, USD, SAN, Disease, Growth, Patient, Novartis, MAP, Revenue, Treatment, Route of administration, European Commission, Food and Drug Administration Amendments Act of 2007, EMA, Prevalence, Diagnosis, PTC Therapeutics, Pharmaceutical industry, Medical device, Medical imaging, Nusinersen, Onasemnogene abeparvovec, Risdiplam

SAN FRANCISCO, Jan. 11, 2023 /PRNewswire/ -- The global spinal muscular atrophy treatment market size is expected to reach USD 18.0 billion by 2030, according to a new study by Grand View Research Inc.

Key Points: 
  • SAN FRANCISCO, Jan. 11, 2023 /PRNewswire/ -- The global spinal muscular atrophy treatment market size is expected to reach USD 18.0 billion by 2030, according to a new study by Grand View Research Inc.
  • For instance, in July 2021, F. Hoffmann-La Roche Ltd launched Evrysdi (risdiplam) for the treatment of patient with spinal muscular atrophy in India.
  • Thus, increasing number of product approvals is expected to drive the spinal muscular atrophy treatment market.
  • Grand View Research has segmented the global spinal muscular atrophy treatment market based on type, application, technology, end-use, and region:
    Spinal Muscular Atrophy Treatment Market - Type Outlook (Revenue, USD Million, 2018 - 2030)

OSNexus Announces QuantaStor 6 with Seagate AP Server Integration

Retrieved on: 
Monday, January 9, 2023
Seagate, EC, VAR, FC, AP, Support, WUI, OpenZFS, AMD, Bonneville, Linux, OEM, Supermicro, Video game console

BELLEVUE, Wash., Jan. 9, 2023 /PRNewswire-PRWeb/ -- OSNexus, the leading developer of grid-scale software-defined storage solutions, today announced the recent release of QuantaStor 6.0 delivering the latest in software-defined technology and support.

Key Points: 
  • QuantaStor 6, one of our largest and most comprehensive releases to date, adds numerous product improvements, the latest hardware support, and integration with Seagate AP storage server platforms.
  • QuantaStor 6.0 is now available to all new and existing customers with active software subscriptions and brings numerous performance optimizations, new features, and support for the latest server platforms from Supermicro & Seagate.
  • "QuantaStor 6 brings over 150 product improvements, making it one of our most comprehensive releases to date," said Steven Umbehocker, CEO of OSNexus.
  • Seagate AP Server Support - QuantaStor now integrates with the full line of Seagate AP storage servers based on AMD processors (Bonneville series) including the Seagate 5U84 AP, Seagate 2U24 AP, and Seagate 2U12 AP.

Secura Bio, Inc. Receives Orphan Drug Designation in Europe for Duvelisib for the Treatment of Patients with Peripheral T-cell Lymphoma

Retrieved on: 
Monday, January 9, 2023
Duvelisib, EC, Food, Royal commission, PI3K, Patient, PTCL, Chronic lymphocytic leukemia, US Foods, Lymphocytosis, European Commission, Sustenance, Peripheral T-cell lymphoma, Marketing, Pharmaceutical industry, EU

Duvelisib was previously granted orphan drug designation by the United States Food and Drug Administration.

Key Points: 
  • Duvelisib was previously granted orphan drug designation by the United States Food and Drug Administration.
  • Orphan Drug Designation in the EU is granted by the EC based on a positive opinion issued by the European Medicines Agency Committee for Orphan Medicinal Products.
  • "This Orphan Drug Designation recognizes the significant unmet need in patients with PTCL, especially those with relapsed/refractory disease.
  • "Secura Bio is dedicated to developing duvelisib for the treatment of patients with difficult-to-treat cancers, which includes relapsed/refractory PTCL.

Mitsubishi Corporation and ENEOS launch a Joint Venture for Last One Mile Delivery Business based at Gas Stations

Retrieved on: 
Thursday, January 5, 2023
Growth, JV, SS, ENEOS, MC, EC, DX, Retail, Food industry

Furthermore, the fact that SS tend to be already optimized to accommodate smooth inbound and outbound traffic makes them ideal logistics hubs.

Key Points: 
  • Furthermore, the fact that SS tend to be already optimized to accommodate smooth inbound and outbound traffic makes them ideal logistics hubs.
  • Using ENEOS's existing SS network should also help to minimize any additional costs associated with setting up the delivery points.
  • In the delivery industry, the growth of online shopping has increased home deliveries, which has led to greater demand for more efficient last-mile services.
  • During that time, MC aims to enhance its cross-industry DX functions and parlay real-world DX projects into greater business value.